153 related articles for article (PubMed ID: 37252102)
1. Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor.
Willems HMG; Edwards S; Boffey HK; Chawner SJ; Green C; Romero T; Winpenny D; Skidmore J; Clarke JH; Andrews SP
RSC Med Chem; 2023 May; 14(5):934-946. PubMed ID: 37252102
[TBL] [Abstract][Full Text] [Related]
2. The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K).
Aldred GG; Rooney TPC; Willems HMG; Boffey HK; Green C; Winpenny D; Skidmore J; Clarke JH; Andrews SP
RSC Med Chem; 2023 Oct; 14(10):2035-2047. PubMed ID: 37859710
[TBL] [Abstract][Full Text] [Related]
3. The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool Molecules.
Rooney TPC; Aldred GG; Boffey HK; Willems HMG; Edwards S; Chawner SJ; Scott DE; Green C; Winpenny D; Skidmore J; Clarke JH; Andrews SP
J Med Chem; 2023 Jan; 66(1):804-821. PubMed ID: 36516442
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Structure-Activity Relationship Study of (
Manz TD; Sivakumaren SC; Ferguson FM; Zhang T; Yasgar A; Seo HS; Ficarro SB; Card JD; Shim H; Miduturu CV; Simeonov A; Shen M; Marto JA; Dhe-Paganon S; Hall MD; Cantley LC; Gray NS
J Med Chem; 2020 May; 63(9):4880-4895. PubMed ID: 32298120
[TBL] [Abstract][Full Text] [Related]
5. Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode.
Boffey HK; Rooney TPC; Willems HMG; Edwards S; Green C; Howard T; Ogg D; Romero T; Scott DE; Winpenny D; Duce J; Skidmore J; Clarke JH; Andrews SP
J Med Chem; 2022 Feb; 65(4):3359-3370. PubMed ID: 35148092
[TBL] [Abstract][Full Text] [Related]
6. Nuclear localizations of phosphatidylinositol 5-phosphate 4-kinases α and β are dynamic and independently regulated during starvation-induced stress.
Droubi A; Bulley SJ; Clarke JH; Irvine RF
Biochem J; 2016 Jul; 473(14):2155-63. PubMed ID: 27208178
[TBL] [Abstract][Full Text] [Related]
7. Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors.
Sivakumaren SC; Shim H; Zhang T; Ferguson FM; Lundquist MR; Browne CM; Seo HS; Paddock MN; Manz TD; Jiang B; Hao MF; Krishnan P; Wang DG; Yang TJ; Kwiatkowski NP; Ficarro SB; Cunningham JM; Marto JA; Dhe-Paganon S; Cantley LC; Gray NS
Cell Chem Biol; 2020 May; 27(5):525-537.e6. PubMed ID: 32130941
[TBL] [Abstract][Full Text] [Related]
8. Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors.
Manz TD; Sivakumaren SC; Yasgar A; Hall MD; Davis MI; Seo HS; Card JD; Ficarro SB; Shim H; Marto JA; Dhe-Paganon S; Sasaki AT; Boxer MB; Simeonov A; Cantley LC; Shen M; Zhang T; Ferguson FM; Gray NS
ACS Med Chem Lett; 2020 Mar; 11(3):346-352. PubMed ID: 32184968
[TBL] [Abstract][Full Text] [Related]
9. In B cells, phosphatidylinositol 5-phosphate 4-kinase-α synthesizes PI(4,5)P2 to impact mTORC2 and Akt signaling.
Bulley SJ; Droubi A; Clarke JH; Anderson KE; Stephens LR; Hawkins PT; Irvine RF
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10571-6. PubMed ID: 27601656
[TBL] [Abstract][Full Text] [Related]
10. A homogeneous, high-throughput assay for phosphatidylinositol 5-phosphate 4-kinase with a novel, rapid substrate preparation.
Davis MI; Sasaki AT; Shen M; Emerling BM; Thorne N; Michael S; Pragani R; Boxer M; Sumita K; Takeuchi K; Auld DS; Li Z; Cantley LC; Simeonov A
PLoS One; 2013; 8(1):e54127. PubMed ID: 23326584
[TBL] [Abstract][Full Text] [Related]
11. Evolutionarily conserved structural changes in phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) isoforms are responsible for differences in enzyme activity and localization.
Clarke JH; Irvine RF
Biochem J; 2013 Aug; 454(1):49-57. PubMed ID: 23758345
[TBL] [Abstract][Full Text] [Related]
12. Development of potent and selective degraders of PI5P4Kγ.
Ji W; Wang ES; Manz TD; Jiang J; Donovan KA; Abulaiti X; Fischer ES; Cantley LC; Zhang T; Gray NS
Eur J Med Chem; 2023 Feb; 247():115027. PubMed ID: 36584631
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases.
Ma G; Duan Y; Huang X; Qian CX; Chee Y; Mukai S; Cui J; Samad A; Matsubara JA; Kazlauskas A; D'Amore PA; Gu S; Lei H
Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3935-43. PubMed ID: 27472081
[TBL] [Abstract][Full Text] [Related]
14. Distribution and localization of phosphatidylinositol 5-phosphate, 4-kinase alpha and beta in the brain.
Noch EK; Yim I; Milner TA; Cantley LC
J Comp Neurol; 2021 Feb; 529(2):434-449. PubMed ID: 32449185
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of PI5P4Kα/β disrupts cell energy metabolism and selectively kills p53-null tumor cells.
Chen S; Chandra Tjin C; Gao X; Xue Y; Jiao H; Zhang R; Wu M; He Z; Ellman J; Ha Y
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34001596
[TBL] [Abstract][Full Text] [Related]
16. Expanding role of PI5P4Ks in cancer: A promising druggable target.
Arora GK; Palamiuc L; Emerling BM
FEBS Lett; 2022 Jan; 596(1):3-16. PubMed ID: 34822164
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay.
Uba AI; Yelekçi K
J Biomol Struct Dyn; 2018 Sep; 36(12):3231-3245. PubMed ID: 28938863
[TBL] [Abstract][Full Text] [Related]
18. The function of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) explored using a specific inhibitor that targets the PI5P-binding site.
Clarke JH; Giudici ML; Burke JE; Williams RL; Maloney DJ; Marugan J; Irvine RF
Biochem J; 2015 Mar; 466(2):359-67. PubMed ID: 25495341
[TBL] [Abstract][Full Text] [Related]
19. Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.
Emerling BM; Hurov JB; Poulogiannis G; Tsukazawa KS; Choo-Wing R; Wulf GM; Bell EL; Shim HS; Lamia KA; Rameh LE; Bellinger G; Sasaki AT; Asara JM; Yuan X; Bullock A; Denicola GM; Song J; Brown V; Signoretti S; Cantley LC
Cell; 2013 Nov; 155(4):844-57. PubMed ID: 24209622
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ), a lipid signalling enigma.
Giudici ML; Clarke JH; Irvine RF
Adv Biol Regul; 2016 May; 61():47-50. PubMed ID: 26710750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
